Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1152/ajpregu.00212.2010

http://scihub22266oqcxt.onion/10.1152/ajpregu.00212.2010
suck pdf from google scholar
20702802!2980457!20702802
unlimited free pdf from europmc20702802    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20702802&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid20702802      Am+J+Physiol+Regul+Integr+Comp+Physiol 2010 ; 299 (5): R1183-91
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Heme oxygenase activity as a determinant of the renal hemodynamic response to low-dose ANG II #MMPMID20702802
  • Nath KA; Hernandez MC; Croatt AJ; Katusic ZS; Juncos LA
  • Am J Physiol Regul Integr Comp Physiol 2010[Nov]; 299 (5): R1183-91 PMID20702802show ga
  • ANG II causes renal injury through hemodynamic and other effects, and pressor doses of ANG II induce heme oxygenase-1 (HO-1) as a protective response. The present studies examined the hemodynamic effects of more clinically relevant, lower doses of ANG II and the role of HO activity in influencing these effects. Under euvolemic conditions, ANG II increased arterial pressure and renal vascular resistance. ANG II did not induce oxidative stress, inflammation/injury-related gene expression, or proteinuria and did not alter extrarenal vascular reactivity. At these doses, ANG II failed to increase HO-1 or HO-2 mRNA expression or HO activity. Inhibiting HO activity in ANG II-treated rats by tin mesoporphyrin further increased renal vascular resistances, decreased renal blood flow, and blunted the rise in arterial pressure without inducing oxidative stress or altering expression of selected vasoactive/injury/inflammation-related genes; tin mesoporphyrin did not alter vasorelaxation of mesenteric resistor vessels. We conclude that in this model renal vasoconstriction occurs without the recognized adverse effects of ANG II on glomerular filtration rate, renal blood flow, oxidative stress, vascular reactivity, proteinuria, and injury-related gene expression; renal HO activity is essential in preserving perfusion of the ANG II-exposed kidney. These findings represent an uncommon example wherein function of a stressed organ (by ANG II), but not that of the unstressed organ, requires intact renal HO activity, even when the imposed stress neither induces HO-1 nor HO activity. These findings may be germane to conditions attended by heightened ANG II levels, ineffective renal perfusion, and susceptibility to acute kidney injury.
  • |Angiotensin II/*administration & dosage[MESH]
  • |Animals[MESH]
  • |Aorta/drug effects[MESH]
  • |Blood Pressure/drug effects[MESH]
  • |Dose-Response Relationship, Drug[MESH]
  • |Enzyme Inhibitors/pharmacology[MESH]
  • |Gene Expression Regulation, Enzymologic[MESH]
  • |Heme Oxygenase (Decyclizing)/antagonists & inhibitors/genetics/*metabolism[MESH]
  • |Hemodynamics/*drug effects[MESH]
  • |Infusion Pumps, Implantable[MESH]
  • |Infusions, Intravenous[MESH]
  • |Kidney/*blood supply/*drug effects/enzymology[MESH]
  • |Male[MESH]
  • |Mesenteric Arteries/drug effects[MESH]
  • |Metalloporphyrins/pharmacology[MESH]
  • |Oxidative Stress[MESH]
  • |RNA, Messenger/metabolism[MESH]
  • |Rats[MESH]
  • |Rats, Sprague-Dawley[MESH]
  • |Renal Circulation/*drug effects[MESH]
  • |Vascular Resistance/drug effects[MESH]
  • |Vasoconstriction/drug effects[MESH]
  • |Vasoconstrictor Agents/pharmacology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box